List of Tables
Table 1. Global Drugs of Abuse Testing Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Drugs of Abuse Testing Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Drugs of Abuse Testing Market Competitive Situation by Manufacturers in 2024
Table 4. Global Drugs of Abuse Testing Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Drugs of Abuse Testing Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Drugs of Abuse Testing Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Drugs of Abuse Testing Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Drugs of Abuse Testing Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Drugs of Abuse Testing, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Drugs of Abuse Testing, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drugs of Abuse Testing, Product Type & Application
Table 12. Global Key Manufacturers of Drugs of Abuse Testing, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drugs of Abuse Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of Abuse Testing as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drugs of Abuse Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Drugs of Abuse Testing Sales by Region (2020-2025) & (K Units)
Table 18. Global Drugs of Abuse Testing Sales Market Share by Region (2020-2025)
Table 19. Global Drugs of Abuse Testing Sales by Region (2026-2031) & (K Units)
Table 20. Global Drugs of Abuse Testing Sales Market Share by Region (2026-2031)
Table 21. Global Drugs of Abuse Testing Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Drugs of Abuse Testing Revenue Market Share by Region (2020-2025)
Table 23. Global Drugs of Abuse Testing Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Drugs of Abuse Testing Revenue Market Share by Region (2026-2031)
Table 25. North America Drugs of Abuse Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Drugs of Abuse Testing Sales by Country (2020-2025) & (K Units)
Table 27. North America Drugs of Abuse Testing Sales by Country (2026-2031) & (K Units)
Table 28. North America Drugs of Abuse Testing Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Drugs of Abuse Testing Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Drugs of Abuse Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Drugs of Abuse Testing Sales by Country (2020-2025) & (K Units)
Table 32. Europe Drugs of Abuse Testing Sales by Country (2026-2031) & (K Units)
Table 33. Europe Drugs of Abuse Testing Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Drugs of Abuse Testing Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Drugs of Abuse Testing Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Drugs of Abuse Testing Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Drugs of Abuse Testing Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Drugs of Abuse Testing Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Drugs of Abuse Testing Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drugs of Abuse Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Drugs of Abuse Testing Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Drugs of Abuse Testing Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Drugs of Abuse Testing Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Drugs of Abuse Testing Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Drugs of Abuse Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Drugs of Abuse Testing Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Drugs of Abuse Testing Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Drugs of Abuse Testing Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Drugs of Abuse Testing Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Drugs of Abuse Testing Sales (K Units) by Type (2020-2025)
Table 51. Global Drugs of Abuse Testing Sales (K Units) by Type (2026-2031)
Table 52. Global Drugs of Abuse Testing Sales Market Share by Type (2020-2025)
Table 53. Global Drugs of Abuse Testing Sales Market Share by Type (2026-2031)
Table 54. Global Drugs of Abuse Testing Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Drugs of Abuse Testing Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Drugs of Abuse Testing Revenue Market Share by Type (2020-2025)
Table 57. Global Drugs of Abuse Testing Revenue Market Share by Type (2026-2031)
Table 58. Global Drugs of Abuse Testing Price (US$/Unit) by Type (2020-2025)
Table 59. Global Drugs of Abuse Testing Price (US$/Unit) by Type (2026-2031)
Table 60. Global Drugs of Abuse Testing Sales (K Units) by Application (2020-2025)
Table 61. Global Drugs of Abuse Testing Sales (K Units) by Application (2026-2031)
Table 62. Global Drugs of Abuse Testing Sales Market Share by Application (2020-2025)
Table 63. Global Drugs of Abuse Testing Sales Market Share by Application (2026-2031)
Table 64. Global Drugs of Abuse Testing Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Drugs of Abuse Testing Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Drugs of Abuse Testing Revenue Market Share by Application (2020-2025)
Table 67. Global Drugs of Abuse Testing Revenue Market Share by Application (2026-2031)
Table 68. Global Drugs of Abuse Testing Price (US$/Unit) by Application (2020-2025)
Table 69. Global Drugs of Abuse Testing Price (US$/Unit) by Application (2026-2031)
Table 70. Abbott Company Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Abbott Drugs of Abuse Testing Product
Table 74. Abbott Recent Developments/Updates
Table 75. Thermo Fisher Company Information
Table 76. Thermo Fisher Description and Business Overview
Table 77. Thermo Fisher Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Thermo Fisher Drugs of Abuse Testing Product
Table 79. Thermo Fisher Recent Developments/Updates
Table 80. Roche Company Information
Table 81. Roche Description and Business Overview
Table 82. Roche Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Roche Drugs of Abuse Testing Product
Table 84. Roche Recent Developments/Updates
Table 85. Siemens Healthineers Company Information
Table 86. Siemens Healthineers Description and Business Overview
Table 87. Siemens Healthineers Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Siemens Healthineers Drugs of Abuse Testing Product
Table 89. Siemens Healthineers Recent Developments/Updates
Table 90. Wondfo Biotech Company Information
Table 91. Wondfo Biotech Description and Business Overview
Table 92. Wondfo Biotech Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Wondfo Biotech Drugs of Abuse Testing Product
Table 94. Wondfo Biotech Recent Developments/Updates
Table 95. Randox Company Information
Table 96. Randox Description and Business Overview
Table 97. Randox Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Randox Drugs of Abuse Testing Product
Table 99. Randox Recent Developments/Updates
Table 100. OraSure Company Information
Table 101. OraSure Description and Business Overview
Table 102. OraSure Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. OraSure Drugs of Abuse Testing Product
Table 104. OraSure Recent Developments/Updates
Table 105. Draeger Company Information
Table 106. Draeger Description and Business Overview
Table 107. Draeger Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Draeger Drugs of Abuse Testing Product
Table 109. Draeger Recent Developments/Updates
Table 110. InTec Company Information
Table 111. InTec Description and Business Overview
Table 112. InTec Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. InTec Drugs of Abuse Testing Product
Table 114. InTec Recent Developments/Updates
Table 115. Orient Gene Company Information
Table 116. Orient Gene Description and Business Overview
Table 117. Orient Gene Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Orient Gene Drugs of Abuse Testing Product
Table 119. Orient Gene Recent Developments/Updates
Table 120. Hangzhou Biotest Company Information
Table 121. Hangzhou Biotest Description and Business Overview
Table 122. Hangzhou Biotest Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Hangzhou Biotest Drugs of Abuse Testing Product
Table 124. Hangzhou Biotest Recent Developments/Updates
Table 125. Assure Tech Company Information
Table 126. Assure Tech Description and Business Overview
Table 127. Assure Tech Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Assure Tech Drugs of Abuse Testing Product
Table 129. Assure Tech Recent Developments/Updates
Table 130. Aotai Bio Company Information
Table 131. Aotai Bio Description and Business Overview
Table 132. Aotai Bio Drugs of Abuse Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Aotai Bio Drugs of Abuse Testing Product
Table 134. Aotai Bio Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Drugs of Abuse Testing Distributors List
Table 138. Drugs of Abuse Testing Customers List
Table 139. Drugs of Abuse Testing Market Trends
Table 140. Drugs of Abuse Testing Market Drivers
Table 141. Drugs of Abuse Testing Market Challenges
Table 142. Drugs of Abuse Testing Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drugs of Abuse Testing
Figure 2. Global Drugs of Abuse Testing Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drugs of Abuse Testing Market Share by Type: 2024 & 2031
Figure 4. Urine Testing Product Picture
Figure 5. Saliva Testing Product Picture
Figure 6. Blood Testing Product Picture
Figure 7. Hair and Sweat Testing Product Picture
Figure 8. Others Product Picture
Figure 9. Global Drugs of Abuse Testing Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Drugs of Abuse Testing Market Share by Application: 2024 & 2031
Figure 11. Hospital
Figure 12. Law Enforcement
Figure 13. Drug Treatment Center
Figure 14. Laboratory
Figure 15. Others
Figure 16. Global Drugs of Abuse Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Drugs of Abuse Testing Market Size (2020-2031) & (US$ Million)
Figure 18. Global Drugs of Abuse Testing Sales (2020-2031) & (K Units)
Figure 19. Global Drugs of Abuse Testing Average Price (US$/Unit) & (2020-2031)
Figure 20. Drugs of Abuse Testing Report Years Considered
Figure 21. Drugs of Abuse Testing Sales Share by Manufacturers in 2024
Figure 22. Global Drugs of Abuse Testing Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Drugs of Abuse Testing Players: Market Share by Revenue in Drugs of Abuse Testing in 2024
Figure 24. Drugs of Abuse Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Drugs of Abuse Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Drugs of Abuse Testing Sales Market Share by Country (2020-2031)
Figure 27. North America Drugs of Abuse Testing Revenue Market Share by Country (2020-2031)
Figure 28. U.S. Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Drugs of Abuse Testing Sales Market Share by Country (2020-2031)
Figure 31. Europe Drugs of Abuse Testing Revenue Market Share by Country (2020-2031)
Figure 32. Germany Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Drugs of Abuse Testing Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Drugs of Abuse Testing Revenue Market Share by Region (2020-2031)
Figure 39. China Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Taiwan Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Philippines Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America Drugs of Abuse Testing Sales Market Share by Country (2020-2031)
Figure 50. Latin America Drugs of Abuse Testing Revenue Market Share by Country (2020-2031)
Figure 51. Mexico Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Middle East and Africa Drugs of Abuse Testing Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Drugs of Abuse Testing Revenue Market Share by Country (2020-2031)
Figure 56. Turkey Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. UAE Drugs of Abuse Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Global Sales Market Share of Drugs of Abuse Testing by Type (2020-2031)
Figure 60. Global Revenue Market Share of Drugs of Abuse Testing by Type (2020-2031)
Figure 61. Global Drugs of Abuse Testing Price (US$/Unit) by Type (2020-2031)
Figure 62. Global Sales Market Share of Drugs of Abuse Testing by Application (2020-2031)
Figure 63. Global Revenue Market Share of Drugs of Abuse Testing by Application (2020-2031)
Figure 64. Global Drugs of Abuse Testing Price (US$/Unit) by Application (2020-2031)
Figure 65. Drugs of Abuse Testing Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
